Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Re-evaluating Biopsy for Recurrent Glioblastoma: A Position Statement by the Christopher Davidson Forum Investigators.

Neurosurgery - 15 Jun 2021

Nduom Edjah K, Gephart Melanie Hayden, Chheda Milan G, Suva Mario L, Amankulor Nduka, Battiste James D, Campian Jian L, Dacey Ralph G, Das Sunit, Fecci Peter E, Hadjipanayis Constantinos G, Hoang Kimberly B, Jalali Ali, Orringer Daniel, Patel Akash J, Placantonakis Dimitris, Rodriguez Analiz, Yang Isaac, Yu Jennifer S, Zipfel Greg J, Dunn Gavin P, Leuthardt Eric C, Kim Albert H

Abstract excerpt

Patients with glioblastoma (GBM) need bold new approaches to their treatment, yet progress has been hindered by a relative inability to dynamically track treatment response, mechanisms of resistance, evolution of targetable mutations, and changes in mutational burden. We are writing on behalf of a multidisciplinary group of academic neuro-oncology professionals who met at the collaborative Christopher Davidson...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brain Neoplasms

Share to Glioblastoma

Share to Mutation

Share to Neoplasm Recurrence, Local

Source

Identifiers

PMID: 33862619
DOI: 10.1093/neuros/nyab063

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Re-evaluating Biopsy for Recurrent Glioblastoma: A Position Statement by the Christopher Davidson Forum Investigators.PMID 33862619Read ↗

Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma.Semantic proximity Read ↗

Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma.Semantic proximity Read ↗

Glioblastoma Standard of Care: Effects on Tumor Evolution and Reverse Translation in Preclinical ModelsSemantic proximity Read ↗

Longitudinal multi-omics characterization of the malignant evolution in multirelapsing glioblastomaSemantic proximity Read ↗

Glioblastoma Standard of Care: Effects on Tumor Evolution and Reverse Translation in Preclinical ModelsSemantic proximity Read ↗

Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution.Semantic proximity Read ↗

Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastomaSemantic proximity Read ↗

Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of neuropathology in the management of progressive glioblastoma in adults.Semantic proximity Read ↗

Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent GlioblastomaSemantic proximity Read ↗

Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making.Semantic proximity Read ↗

Clinical Application of Next Generation Sequencing in Recurrent GlioblastomaSemantic proximity Read ↗

Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.